XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
DIVESTITURES (Notes)
 3 Months Ended
Mar. 31, 2019
Acquisitions and Divestitures [Abstract]  
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
DIVESTITURES AND OTHER ARRANGEMENTS

Divestitures

The following table summarizes proceeds, gains and royalty income resulting from divestitures. Revenue and pretax earnings related to all divestitures and assets held-for-sale were not material in all periods presented (excluding divestiture gains).
 
Three Months Ended March 31,
 
Proceeds(a)
 
Divestiture Gains
 
Royalty Income
Dollars in Millions
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Diabetes Business
$
164

 
$
88

 
$
—

 
$
—

 
$
(165
)
 
$
(162
)
Erbitux* Business
5

 
59

 
—

 
—

 
—

 
(47
)
Manufacturing Operations
2

 
158

 
—

 
—

 
—

 
—

Mature Brands and Other
—

 
70

 
—

 
(45
)
 
(1
)
 
(1
)
Total
$
171

 
$
375

 
$
—

 
$
(45
)
 
$
(166
)
 
$
(210
)
(a)
Includes royalties received subsequent to the related sale of the asset or business.

Manufacturing Operations

In 2017, BMS sold its small molecule active pharmaceutical ingredient manufacturing operations in Swords, Ireland to SK Biotek for approximately $165 million, subject to certain adjustments. The transaction was accounted for as a sale of a business and initial proceeds of $158 million were received in the first quarter of 2018. SK Biotek will provide certain manufacturing services for BMS through 2022.

Assets Held-For-Sale

In 2018, BMS agreed to sell its UPSA consumer health business for $1.6 billion. The transaction is expected to close in July 2019 and will be accounted for as a sale of a business. Assets were reclassified to assets held-for-sale and included within Prepaid expenses and other and liabilities were reclassified to liabilities related to assets held-for-sale and included within Accrued liabilities. The following table summarizes the net assets held-for-sale as of March 31, 2019 and December 31, 2018.
Dollars in Millions
March 31,
2019
 
December 31,
2018
Receivables
$
73

 
$
79

Inventories
87

 
81

Property, plant and equipment
190

 
187

Goodwill
127

 
127

Others
6

 
5

Assets held-for-sale
$
483

 
$
479

 
 
 
 
Accounts payable
$
38

 
$
35

Accrued liabilities
59

 
78

Deferred income taxes
24

 
25

Other liabilities
23

 
14

Liabilities related to assets held-for-sale
$
144

 
$
152

 
 
 
 
Net assets held-for-sale
$
339

 
$
327